Long-term Outcomes of Half-dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy

被引：0
|
作者：
Cheng, Zhihang [1 ]
Babiker, Salma [1 ]
Lenfestey, Pauline [1 ]
Beare, Nick [1 ]
Pearce, Ian A. [1 ]
机构：
[1] Royal Liverpool Univ Hosp, St Pauls Eye Unit, Liverpool, Merseyside, England
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2019年 / 60卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
5002
引用
收藏
页数：3
相关论文
共 50 条
  • [41] FLUORESCEIN ANGIOGRAPHY-GUIDED PHOTODYNAMIC THERAPY WITH HALF-DOSE VERTEPORFIN FOR CHRONIC CENTRAL SEROUS CHORIORETINOPATHY
    Koytak, Arif
    Erol, Kazim
    Coskun, Erol
    Asik, Nihal
    Ozturk, Hakan
    Ozerturk, Yusuf
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2010, 30 (10): : 1698 - 1703
  • [42] Foveal and Extrafoveal Effects of Half-Dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy: A Cohort Study
    Pinto, Christophe
    Sousa, Keissy
    Oliveira, Eliana
    Mendonca, Luis
    Gentil, Rita
    Queiros, Lara
    Falcao, Manuel
    SEMINARS IN OPHTHALMOLOGY, 2022, 37 (02) : 153 - 157
  • [43] Outcome of half-dose photodynamic therapy in chronic central serous chorioretinopathy with fovea-involving atrophy
    Thomas J. van Rijssen
    Elon H. C. van Dijk
    Paula Scholz
    Robert E. MacLaren
    Sascha Fauser
    Susan M. Downes
    Carel B. Hoyng
    Camiel J. F. Boon
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2021, 259 : 905 - 910
  • [44] Angiographic and Tomographic Prognostic Factors of Chronic Central Serous Chorioretinopathy Treated with Half-Dose Photodynamic Therapy
    Chung, Chung Yee
    Chan, Yee Yan
    Li, Kenneth K. W.
    OPHTHALMOLOGICA, 2018, 240 (01) : 37 - 44
  • [45] A combination therapy of half-dose verteporfin photodynamic therapy and intravitreal injection of ranibizumab for chronic central serous chorioretinopathy
    Toklu, Yasin
    Cakmak, Hasan Basri
    Yorgun, Mucella Arikan
    Ergun, Sule Berk
    Simsek, Saban
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2012, 42 (04) : 681 - 688
  • [46] Macular sensitivity after half-dose verteporfin photodynamic therapy in central serous chorioretinopathy
    Sanguansak, Thuss
    Pitujaturont, Prapapan
    Yospaiboon, Yosanan
    Sinawat, Suthasinee
    Ratanapakorn, Tanapat
    Bhoomibunchoo, Chavakij
    CLINICAL OPHTHALMOLOGY, 2015, 9 : 2257 - 2261
  • [47] Long-term outcomes of half-fluence photodynamic therapy and eplerenone in chronic central serous chorioretinopathy: A comparative study
    Manayath, George
    Verghese, Shishir
    Ranjan, Ratnesh
    Agrawal, Hitesh
    Khanna, Amishi
    Narendran, Venkatapathy
    Chhablani, Jay
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2021, 31 (06) : 3110 - 3116
  • [48] Long-Term Outcomes of Full-Fluence and Half-Fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy
    Son, Bo Kwon
    Kim, Kiyoung
    Kim, Eung Suk
    Yu, Seung-Young
    OPHTHALMOLOGICA, 2019, 241 (02) : 105 - 115
  • [49] Comparison of half-dose versus half-fluence versus standard photodynamic therapy in chronic central serous chorioretinopathy
    Altinel, Meltem Guzin
    Kanra, Ayse Yagmur
    Totuk, Ozgun Melike Gedar
    Ardagil, Aylin
    Kabadayi, Kerem
    PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2021, 33
  • [50] RETINAL SENSITIVITY AFTER PHOTODYNAMIC THERAPY WITH HALF-DOSE VERTEPORFIN FOR CHRONIC CENTRAL SEROUS CHORIORETINOPATHY Short-Term Results
    Fujita, Kyoko
    Yuzawa, Mitsuko
    Mori, Ryusaburou
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2011, 31 (04): : 772 - 778
12345